A different thapsigargin schedule, 0.4 mg/kg/injections 3 times per week, is tolerated and effective in reducing Notch1 signaling in TNF-induced synovial M1 macrophages in a Hes1-GFP/TNF transgenic mouse model of rheumatoid arthritis [135]. Here, TNF is linked to rheumatoid arthritis.